ArticleBMC urology2025
Intracorporeal versus extracorporeal urinary diversion during robotic radical cystectomy: outcomes from a large single-institutional study.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A narrative review of the state of urinary diversion: ileal conduit, neobladder, continent cutaneous, and cutaneous ureterostomy.Translational andrology and urology · 2026Review
- Intraoperative pelvic drain placement and postoperative outcomes following robot-assisted radical cystectomy: a contemporary NSQIP analysis.Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver the past decade, there has been a significant increase in the use of robot-assisted radical cystectomy (RARC) with fully intracorporeal urinary diversion. Utilizing data from a single, high-volume institutional database, this study aimed to evaluate and compare perioperative outcomes and complications associated with intracorporeal urinary diversion (ICUD) versus extracorporeal urinary diversion (ECUD) following RARC.
methodsThis study included 405 patients with bladder cancer who underwent RARC at our institution between July 2016 and April 2023. Data were retrospectively reviewed and compared between ICUD and ECUD groups. The 90-day major complications (MC90), 90-day overall complications (OC90), and perioperative and pathological outcomes were evaluated. Statistical analyses were performed using the Pearson chi-square test, Mann-Whitney U test, Kaplan-Meier tests, and multivariable regression analysis.
resultsFollowing RARC, 230 patients underwent ICUD and 175 underwent ECUD. No significant differences in demographics or oncological characteristics were observed between the two groups, except for a higher proportion of females in the ICUD group. Notably, ICUD was associated with significantly reduced median operative time (319 min vs. 370 min, p < 0.01) and lower median estimated blood loss (300 ml vs. 500 ml, p < 0.01). Postoperative recovery was faster in the ICUD group. However, the OC90, MC90, overall survival, and recurrence-free survival were comparable between the two groups.
conclusionsCompared with ECUD, ICUD significantly improved perioperative outcomes, including operative time, estimated blood loss, and postoperative recovery, without compromising long-term oncological survival or complication rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.